Status:
RECRUITING
Cardiometabolic Screening Program
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborating Sponsors:
Private Philanthropic Funds
Conditions:
Breast Cancer
Early-stage Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This research study is being done to implement a screening program for prediabetes, diabetes, dyslipidemia and/or hyperlipidemia, and higher risk of cardiovascular disease in breast cancer survivors. ...
Detailed Description
The investigators propose a prospective cardiometabolic screening program for breast cancer survivors. A formalized screening program may ensure that all patients are receiving these routine screening...
Eligibility Criteria
Inclusion
- Diagnosis of early stage breast cancer
- Completed local and/or systemic therapy at least 3 months ago
- Receiving medical oncology care at through the breast cancer clinics at Johns Hopkins Medical Institute, including the Sidney Kimmel Comprehensive Cancer Center in Baltimore MD and Green Spring Station in Lutherville-Timonium MD, and Sibley Memorial Hospital in Washington D.C.
- Read and speak English
Exclusion
- Metastatic breast cancer
Key Trial Info
Start Date :
June 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT05386719
Start Date
June 3 2022
End Date
June 1 2027
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States, 21231-1000